Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,186 | -4,957 | -3,208 | -1,617 | -6,170 |
| Depreciation Amortization | 119 | 93 | 68 | 43 | 186 |
| Accounts receivable | -378 | -18 | -129 | -98 | 356 |
| Other Working Capital | -986 | -1,063 | -908 | -24 | 571 |
| Other Operating Activity | 1,108 | 343 | 277 | 179 | 166 |
| Operating Cash Flow | $-7,322 | $-5,601 | $-3,901 | $-1,517 | $-4,890 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -30 |
| Common Stock Issued | 7,718 | 7,474 | 7,497 | 627 | 729 |
| Common Stock Repurchased | -329 | -295 | N/A | -96 | -108 |
| Other Financing Activity | 9,642 | 9,666 | 9,347 | 1,541 | 0 |
| Financing Cash Flow | $17,031 | $16,844 | $16,844 | $2,072 | $592 |
| Exchange Rate Effect | 46 | 81 | -85 | -28 | -26 |
| Beginning Cash Position | 1,037 | 1,037 | 1,037 | 1,037 | 5,361 |
| End Cash Position | 10,792 | 12,362 | 13,897 | 1,564 | 1,037 |
| Net Cash Flow | $9,755 | $11,324 | $12,859 | $526 | $-4,324 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,322 | -5,601 | -3,901 | -1,517 | -4,890 |
| Free Cash Flow | -7,322 | -5,601 | -3,901 | -1,517 | -4,890 |